Literature DB >> 33328704

Interventional Oncology Approach to Hepatic Metastases.

Cathal O'Leary1, Michael C Soulen1, Susan Shamimi-Noori1.   

Abstract

Metastatic liver disease is one of the major causes of cancer-related morbidity and mortality. Locoregional therapies offered by interventional oncologists alleviate cancer-related morbidity and in some cases improve survival. Locoregional therapies are often palliative in nature but occasionally can be used with curative intent. This review will discuss important factors to consider prior to palliative and curative intent treatment of metastatic liver disease with locoregional therapy. These factors include those specific to the tumor, liver function, liver reserve, differences between treatment modalities, and patient-specific considerations. Thieme. All rights reserved.

Entities:  

Keywords:  ablation; hepatic metastases; liver reserve; locoregional therapy; transarterial therapy

Year:  2020        PMID: 33328704      PMCID: PMC7732560          DOI: 10.1055/s-0040-1719189

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  82 in total

Review 1.  Radiotherapy for liver metastases: a review of evidence.

Authors:  Morten Høyer; Anand Swaminath; Sean Bydder; Michael Lock; Alejandra Méndez Romero; Brian Kavanagh; Karyn A Goodman; Paul Okunieff; Laura A Dawson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-01       Impact factor: 7.038

Review 2.  Part I: Liver function in oncology: biochemistry and beyond.

Authors:  Kathryn M Field; Chris Dow; Michael Michael
Journal:  Lancet Oncol       Date:  2008-11       Impact factor: 41.316

Review 3.  Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers.

Authors:  Samdeep K Mouli; Ramona Gupta; Neil Sheth; Andrew C Gordon; Robert J Lewandowski
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

4.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Daniel R Wahl; Matthew H Stenmark; Yebin Tao; Erqi L Pollom; Elaine M Caoili; Theodore S Lawrence; Matthew J Schipper; Mary Feng
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

5.  Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients.

Authors:  Jennifer L Peterson; Laura A Vallow; Douglas W Johnson; Michael G Heckman; Nancy N Diehl; Ashley A Smith; Katherine S Tzou; Ricardo Paz-Fumagalli; Siyong Kim; Stephen J Ko; Larry C Daugherty; George P Kim; Norman Brown; Kurt W Mori; Steven J Buskirk
Journal:  Brachytherapy       Date:  2013-08-14       Impact factor: 2.362

6.  Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases.

Authors:  Junichi Shindoh; Ching-Wei D Tzeng; Thomas A Aloia; Steven A Curley; Giuseppe Zimmitti; Steven H Wei; Steven Y Huang; Armeen Mahvash; Sanjay Gupta; Michael J Wallace; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2013-02-03       Impact factor: 5.344

Review 7.  A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90.

Authors:  Jin-Yao Teo; John C Allen; David C Ng; Su-Pin Choo; David W M Tai; Jason P E Chang; Foong-Khoon Cheah; Pierce K H Chow; Brian K P Goh
Journal:  HPB (Oxford)       Date:  2015-12-11       Impact factor: 3.647

8.  Biliary sequelae following radioembolization with Yttrium-90 microspheres.

Authors:  Bassel Atassi; Affaan K Bangash; Robert J Lewandowski; Saad Ibrahim; Laura Kulik; Mary F Mulcahy; Ravi Murthy; Robert K Ryu; Kent T Sato; Frank H Miller; Reed A Omary; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2008-03-17       Impact factor: 3.464

9.  Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.

Authors:  Hiromichi Ito; Chandrakanth Are; Mithat Gonen; Michael D'Angelica; Ronald P Dematteo; Nancy E Kemeny; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg       Date:  2008-06       Impact factor: 12.969

10.  Radiofrequency ablation in the management of liver metastases from breast cancer.

Authors:  C T Sofocleous; R G Nascimento; M Gonen; M Theodoulou; A M Covey; L A Brody; S M Solomon; R Thornton; Y Fong; G I Getrajdman; K T Brown
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

View more
  1 in total

1.  Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies.

Authors:  Attila Kovács; Peter Bischoff; Hathal Haddad; Willi Zhou; Susanne Temming; Andreas Schäfer; Hannah Spallek; Lucas Kaupe; György Kovács; Michael Pinkawa
Journal:  J Pers Med       Date:  2022-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.